TGFBR2 and adenocarcinoma: The mutations at Vps13d codon 295 and Tgfbr2 codon 549, found in the DMBA-treated organoid-derived adenocarcinomas were observed also in the passaged nodules, diagnosed as SCCs (Supplementary Figures S5A,B).